Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans

Journal of Bioscience and Bioengineering

Volumn 113, Issue 5, 2012, Pages 587-591

  Ishizuka, Akihiro ^a   Tomizuka, Kotomi ^b   Aoki, Ryo ^a   Nishijima, Tomohiko ^a   Saito, Yasuo ^a   Inoue, Ryo ^c   Ushida, Kazunari ^c   Mawatari, Takashi ^a   Ikeda, Takayuki ^b  

^a Glico Dairy Products Co Ltd   (Japan)

^b FUJI WOMEN'S UNIVERSITY   (Japan)

^c KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

Bifidobacterium animalis subsp. lactis GCL2505; Human study; Intestinal bifidobacteria; Probiotics; QPCR

Indexed keywords

BIFIDOBACTERIA; BIFIDOBACTERIUM; HUMAN STUDY; PROBIOTICS; QPCR;

POLYMERASE CHAIN REACTION;

BACTERIA;

GASTROINTESTINAL AGENT; GCL 2505; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL COUNT; BIFIDOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; BIFIDOBACTERIUM ANGLATUM; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BREVE; BIFIDOBACTERIUM CATENULATUM; BIFIDOBACTERIUM DENTIUM; BIFIDOBACTERIUM LONGUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEFECATION FREQUENCY; DIGESTIVE TRACT PARAMETERS; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; BIFIDOBACTERIUM; BIODIVERSITY; COLONY COUNT, MICROBIAL; CONSTIPATION; CROSS-OVER STUDIES; DEFECATION; DOUBLE-BLIND METHOD; FECES; FEMALE; HUMANS; INTESTINES; MALE; METAGENOME; REAL-TIME POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM ANIMALIS SUBSP. LACTIS;

EID: 84859903892     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2011.12.016     Document Type: Article

References (37)

1. Fuller R. Probiotics in man and animals. J. Bacteriol. 1989, 66:365-378.
2. Gibson G.R., Roberfroid M.B. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995, 125:1401-1412.
3. Mitsuoka T. Taxanomy and ecology of bifidobacteria. Bifidobacteria Microflora 1984, 3:11-28.
4. Tanaka R. Clinical effects of bifidobacteria and lactobacilli. Probiotics: Prospects of use in opportunistic infections. Old Herborn University seminar monograph 1995, vol. 8:141b-157b. Institute for Microbiology and Biochemistry, Herborn-Dill, Germany. F. R., H. P.J., R. V., W. D.V.D. (Eds.).
5. Larsen C.N., Nielsen S., Kæstel P., Brockmann E., Bennedsen M., Christensen H.R., Eskesen D.C., Jacobsen B.L., Michaelsen K.F. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults. Eur. J. Clin. Nutr. 2006, 60:1284-1293.
6. Matsumoto M., Imai T., Hironaka T., Kume H., Watanabe M., Benno Y. Effect of yogurt with Bifidobacterium lactis LKM512 in improving fecal microflora and defecation of healthy volunteers. Chonai Saikingaku Zasshi 2001, 14:97-102. (in Japanese).
7. Shimakawa Y., Matsubara S., Yuki N., Ikeda M., Ishikawa F. Evaluation of Bifidobacterium breve strain Yakult-fermented soymilk as a probiotic food. Int. J. Food Microbiol. 2003, 81:131-136.
8. Yaeshima T., Takahashi S., Matsumoto N., Ishibashi N., Hayasawa H., Iino H. Effect of Yogurt Containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency. Biosci. Microflora 1997, 16:73-77.
9. Araya M., Morelli L., Reid G., Sanders M.E., Stanton C., Pineiro M., Ben E.P. Guidelines for the evaluation of probiotics in food. Joint FAO/WHO working group report on drafting guidelines for the evaluation of probiotics in food, London, ON, Canada 2002.
10. +-ATPase activity in Bifidobacterium with special reference to acid tolerance. Int. J. Food Microbiol. 2004, 93:109-113.
11. Meile L., Lucwig W., Rueger U., Gut C., Kaufmann P., Dasen G., Wenger S., Teuber M. Bifidobacterium lactis sp. nov., a moderately oxygen tolerant species isolated from fermented milk. Syst. Appl. Microbiol. 1997, 20:57-64.
12. Dinote A., Marques T.M., Sakamoto K., Fukiya S., Watanabe J., Ito S., Yokota A. Population dynamics of Bifidobacterium species in human feces during raffinose administration monitored by fluorescence in situ hybridization-flow cytometry. Appl. Environ. Microbiol. 2006, 72:7739-7747.
13. Haarman M., Knol J. Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl. Environ. Microbiol. 2005, 71:2318-2324.
14. Matsuki T., Watanabe K., Fujimoto J., Kado Y., Takada T., Matsumoto K., Tanaka R. Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl. Environ. Microbiol. 2004, 70:167-173.
15. Requena T., Burton J., Matsuki T., Munro K., Simon M.A., Tanaka R., Watanabe K., Tannock G.W. Identification, detection, and enumeration of human Bifidobacterium species by PCR targeting the transaldolase gene. Appl. Environ. Microbiol. 2002, 68:2420-2427.
16. Rinttila T., Kassinen A., Malinen E., Krogius L., Palva A. Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 2004, 97:1166-1177.
17. Takada T., Matsumoto K., Nomoto K. Development of multicolor FISH method for analysis of seven Bifidobacterium species in human feces. J. Microbiol. Methods 2004, 58:413-421.
18. Matsuki T., Watanabe K., Tanaka R., Fukuda M., Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl. Environ. Microbiol. 1999, 65:4506-4512.
19. Mutai M., Tanaka R. Ecology of Bifidobacterium in the human intestinal flora. Bifidobacteria Microflora 1987, 6:33-41.
20. Matsuki T. Procedure of DNA extraction from fecal sample for the analysis of intestinal microflora. Chonai Saikingaku Zasshi 2006, 20:259-262. (in Japanese).
21. Malinen E., Kassinen A., Rinttila T., Palva A. Comparison of real-time PCR with SYBR Green I or 5'-nuclease assays and dot-blot hybridization with rDNA-targeted oligonucleotide probes in quantification of selected faecal bacteria. Microbiology 2003, 149:269-277.
22. Nadkarni M.A., Martin F.E., Jacques N.A., Hunter N. Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 2002, 148:257-266.
23. Bezkorovainy A. Probiotics: determinants of survival and growth in the gut. Am. J. Clin. Nutr. 2001, 73:399S-405S.
24. Bouhnik Y., Pochart P., Marteau P., Arlet G., Goderel L., Rambaud J.C. Fecal recovery in humans of viable Bifidobacterium sp. ingested in fermented milk. Gastroenterology 1992, 102:875-878.
25. Fujimoto J., Tanigawa K., Kudo Y., Makino H., Watanabe K. Identification and quantification of viable Bifidobacterium breve strain Yakult in human feces by using strain-specific primers and propidium monoazide. J. Appl. Microbiol. 2010, 110:209-216.
26. Fujiwara S., Seto Y., Kimura A., Hashiba H. Intestinal transit of an orally administered streptomycin- rifampicin-resistant variant of Bifidobacterium longum SBT2928: its long-term survival and effect on the intestinal microflora and metabolism. J. Appl. Microbiol. 2001, 90:43-52.
27. Maruo T., Sakamoto M., Toda T., Benno Y. Monitoring the cell number of Lactococcus lactis subsp. cremoris FC in human feces by real-time PCR with strain-specific primers designed using the RAPD technique. Int. J. Food Microbiol. 2006, 110:69-76.
28. Rochet V., Rigottier-Gois L., Ledaire A., Andrieux C., Sutren M., Rabot A., Mogenet A., Bresson J., Cools S., Picard C., Goupli-Feuillerat N., Dore J. Survival of Bifidobacterium animalis DN-173 010 in the faecal microbiota after administration in lyophilized form or in fermented product-a randomized study in healthy adults. J. Mol. Microbiol. Biotechnol. 2008, 14:128-136.
29. Takahashi H., Fujita T., Suzuki Y., Benno Y. Monitoring and survival of Lactobacillus gasseri SBT2055 in the human intestinal tract. Microbiol. Immunol. 2006, 50:867-870.
30. Benno Y., Mitsuoka T. Impact of Bifidobacterium longum on human fecal microflora. Microbiol. Immunol. 1992, 36:683-694.
31. Matto J., Fonden R., Tolvanen T., Wright A.V., Vilpponen-Salmela T., Satokari R., Saarela M. Intestinal survival and persistence of probiotic Lactobacillus and Bifidobacterium strains administered in triple-strain yoghurt. Int. Dairy J. 2006, 16:1174-1180.
32. Fujimoto J., Matsuki T., Sasamoto M., Tomii Y., Watanabe K. Identification and quantification of Lactobacillus casei strain Shirota in human feces with strain-specific primers derived from randomly amplified polymorphic DNA. Int. J. Food Microbiol. 2008, 126:210-215.
33. Matsumoto M., Sakamoto M., Benno Y. Dynamics of fecal microbiota inhospitalized elderly fed probiotic LKM512 yogurt. Microbiol. Immunol. 2009, 53:421-432.
34. Matsumoto M., Tadenuma T., Nakamura K., Kume H., Imai T., Kihara R., Watanabe M., Benno Y. Effect of Bifidobacterium lactis LKM 512 yogurt on fecal microflora in middle to old aged persons. Microb. Ecol. Health D. 2000, 12:77-80.
35. Collado M.C., Moreno Y., Cobo J.M., Mateos J.A., Hernande M. Molecular detection of Bifidobacterium animalis DN-173010 in human feces during fermented milk administration. Food Res. Int. 2006, 39:530-535.
36. Kullen M.J., Amann M.M., O'Shaughnessy M.J., O'Sullivan D.J., Busta F.F., Brady L.J. Differentiation of ingested and endogenous bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J. Nutr. 1996, 127:89-94.
37. Rowland I., Capurso L., Collins K., Cummings J., Delzenne N., Goulet O., Guarner F., Marteau P., Meier R. Current level of consensus on probiotic science. Gut Microbes 2010, 1:436-439.